Latest Dividend Reinvestment News

Australian Foundation Investment Company Limited has updated its interim and special dividend details, including foreign currency exchange rates and pricing for its Dividend Reinvestment and Substitution Share Plans.

Scentre Group has announced an ordinary dividend of AUD 0.08905 per security for the six months ending December 2025, with a Dividend Reinvestment Plan option available. The full year results will be released on 24 February 2026.

Argo Investments reported a striking 79% jump in half-year profit to $130.8 million, underpinned by stronger investment income, and announced an 18.5 cents per share fully franked interim dividend.

CAR Group Limited has announced a fully paid ordinary dividend of AUD 0.425 per share for the six months ending December 2025, accompanied by a Dividend Reinvestment Plan (DRP) with no discount.

CAR Group Limited reported a strong half-year result for the period ending 31 December 2025, with revenue up 8% and adjusted net profit rising 11.5%, driven by robust performance across Australia, North America, Latin America, and Asia.

Apiam Animal Health has secured court approval for its corporate scheme, paving the way for a fully franked special dividend payment next month.

Apiam Animal Health Limited has announced a special fully franked dividend of AUD 0.10 per share, with payment scheduled for mid-February 2026. Notably, the company has suspended its dividend reinvestment plan for this payout.

Apiam Animal Health has announced a fully franked special dividend of 10 cents per share, payable before the completion of its proposed acquisition by Adamantem Capital entities. The dividend is conditional on the scheme’s effectiveness and offers shareholders potential tax benefits through franking credits.

BlackRock Investment Management (Australia) Limited has announced estimated cash distributions for four Australian iShares ETFs, outlining key dates and options for investors to reinvest dividends.

Pinnacle Investment Management Group Limited has announced a fully franked ordinary dividend of AUD 0.29 per share for the half-year ending December 2025, with a dividend reinvestment plan available to shareholders.

Pinnacle Investment Management reported a robust 66.6% increase in revenues for the half year ended December 2025, yet profits and earnings per share declined, prompting a cautious outlook despite a healthy interim dividend.

Apiam Animal Health shareholders have predominantly elected to receive scrip or mixed consideration in the proposed acquisition, with a special dividend of 10 cents per share proposed pending scheme approval.